• Pre-clinical Services
  • 125 I ADME Studies
  • Imaging ADME Studies
  • Antibody Studies
  • Cell Trafficking
  • Oncology
  • Neurology
  • Cardio-cerebrovascular Diseases
  • Others
  • Clinical Services
  • Phase 0
  • Individualized Drug Therapy
  • Regulatory Services
  • Imaging Analysis
  • Contact Us
  • Home > Who We Are

    MITRO Biotech Co., Ltd. is a molecular imaging contract research organization (MI-CRO) company in China. MITRO provides outstanding contract research for new drug development using Radiolabeling and Molecular Imaging technique. MITRO provides integrated solutions, including drug screening, biodistribution, pharmacokinetics and pharmacodynamics. MITRO provides the translational research service from nude mice, rats, monkeys to human. MITRO focus on cancer, coronary heart disease, Alzheimer’s disease, epilepsy, Parkinson disease, Rheumatoid arthritis, Diabetes, gene expression, stem cell research, etc. PET molecular imaging which has the outstanding advantages of in vivo imaging, dynamic quantitative, self-control and continuous observation can greatly shorten the drug development cycle, reduce the R&D cost, and reduce the risk of failure.